Published in J Cell Sci on October 01, 2001
Pondering the promyelocytic leukemia protein (PML) puzzle: possible functions for PML nuclear bodies. Mol Cell Biol (2002) 2.57
PML nuclear bodies. Cold Spring Harb Perspect Biol (2010) 2.44
Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression. Proc Natl Acad Sci U S A (2004) 2.43
ND10 components relocate to sites associated with herpes simplex virus type 1 nucleoprotein complexes during virus infection. J Virol (2005) 2.36
Transcriptional regulation by AIRE: molecular mechanisms of central tolerance. Nat Rev Immunol (2008) 1.99
Promyelocytic leukemia nuclear bodies associate with transcriptionally active genomic regions. J Cell Biol (2004) 1.74
Nuclear body movement is determined by chromatin accessibility and dynamics. Proc Natl Acad Sci U S A (2004) 1.52
Spatial quantitative analysis of fluorescently labeled nuclear structures: problems, methods, pitfalls. Chromosome Res (2008) 1.26
Recruitment of human cyclin T1 to nuclear bodies through direct interaction with the PML protein. EMBO J (2003) 1.26
Addressing protein localization within the nucleus. EMBO J (2002) 1.18
Mobility of multi-subunit complexes in the nucleus: accessibility and dynamics of chromatin subcompartments. Histochem Cell Biol (2005) 1.17
The cell biology of disease: Acute promyelocytic leukemia, arsenic, and PML bodies. J Cell Biol (2012) 1.17
Gene positioning. Cold Spring Harb Perspect Biol (2010) 1.12
The human Major Histocompatibility Complex as a paradigm in genomics research. Brief Funct Genomic Proteomic (2009) 1.11
Gene expression within a dynamic nuclear landscape. EMBO J (2006) 1.10
Sumoylation at chromatin governs coordinated repression of a transcriptional program essential for cell growth and proliferation. Genome Res (2013) 1.08
Gamma interferon-dependent transcriptional memory via relocalization of a gene locus to PML nuclear bodies. Mol Cell Biol (2010) 1.07
Transcriptional regulation is affected by subnuclear targeting of reporter plasmids to PML nuclear bodies. Mol Cell Biol (2006) 1.03
Phosphorylation and the Cajal body: modification in search of function. Arch Biochem Biophys (2010) 1.03
The nuclear bodies inside out: PML conquers the cytoplasm. Curr Opin Cell Biol (2011) 1.01
The gentle art of gene arrangement: the meaning of gene clusters. Genome Biol (2002) 0.99
Live cell dynamics of promyelocytic leukemia nuclear bodies upon entry into and exit from mitosis. Mol Biol Cell (2008) 0.98
The transcriptional regulator CBP has defined spatial associations within interphase nuclei. PLoS Comput Biol (2006) 0.97
PML promotes MHC class II gene expression by stabilizing the class II transactivator. J Cell Biol (2012) 0.95
Human cytomegalovirus IE1 protein elicits a type II interferon-like host cell response that depends on activated STAT1 but not interferon-γ. PLoS Pathog (2011) 0.95
Segmentation of fluorescence microscopy images for quantitative analysis of cell nuclear architecture. Biophys J (2009) 0.94
Sumoylation of p45/NF-E2: nuclear positioning and transcriptional activation of the mammalian beta-like globin gene locus. Mol Cell Biol (2005) 0.93
Pondering the puzzle of PML (promyelocytic leukemia) nuclear bodies: can we fit the pieces together using an RNA regulon? Biochim Biophys Acta (2008) 0.93
YB-1 functions as a porter to lead influenza virus ribonucleoprotein complexes to microtubules. J Virol (2012) 0.92
Dual functions of histone-lysine N-methyltransferase Setdb1 protein at promyelocytic leukemia-nuclear body (PML-NB): maintaining PML-NB structure and regulating the expression of its associated genes. J Biol Chem (2011) 0.92
PML bodies provide an important platform for the maintenance of telomeric chromatin integrity in embryonic stem cells. Nucleic Acids Res (2013) 0.92
Subcellular transport of EKLF and switch-on of murine adult beta maj globin gene transcription. Mol Cell Biol (2007) 0.88
Reconfiguration of genomic anchors upon transcriptional activation of the human major histocompatibility complex. Genome Res (2008) 0.88
Quantitative analysis of cell nucleus organisation. PLoS Comput Biol (2007) 0.88
Identifying gene locus associations with promyelocytic leukemia nuclear bodies using immuno-TRAP. J Cell Biol (2013) 0.84
Telomeric DNA mediates de novo PML body formation. Mol Biol Cell (2009) 0.83
PML nuclear bodies and SATB1 are associated with HLA class I expression in EBV+ Hodgkin lymphoma. PLoS One (2013) 0.78
Nuclear domain 10-associated proteins recognize and segregate intranuclear DNA/protein complexes to negate gene expression. Virol J (2012) 0.78
Promyelocytic leukemia bodies tether to early endosomes during mitosis. Cell Cycle (2014) 0.77
A Crowdsourced nucleus: understanding nuclear organization in terms of dynamically networked protein function. Biochim Biophys Acta (2014) 0.76
PML nuclear bodies contribute to the basal expression of the mTOR inhibitor DDIT4. Sci Rep (2017) 0.75
A computational approach to understand phenotypic structure and constitutive mechanics relationships of single cells. Ann Biomed Eng (2012) 0.75
The elastin peptide (VGVAPG)3 induces the 3D reorganisation of PML-NBs and SC35 speckles architecture, and accelerates proliferation of fibroblasts and melanoma cells. Histochem Cell Biol (2014) 0.75
Regulation of NF-κB by PML and PML-RARα. Sci Rep (2017) 0.75
A strategy for the rapid multiple alignment of protein sequences. Confidence levels from tertiary structure comparisons. J Mol Biol (1987) 19.30
Enhanced genome annotation using structural profiles in the program 3D-PSSM. J Mol Biol (2000) 10.87
Prediction of protein secondary structure and active sites using the alignment of homologous sequences. J Mol Biol (1987) 9.74
Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet (2003) 5.39
Enhancement of protein modeling by human intervention in applying the automatic programs 3D-JIGSAW and 3D-PSSM. Proteins (2001) 4.85
Does this have a familiar RING? Trends Biochem Sci (1996) 4.80
Modelling protein docking using shape complementarity, electrostatics and biochemical information. J Mol Biol (1997) 4.69
The Ewing family of tumors--a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med (1994) 4.65
Genetic and crystallographic studies of the 3',5'-exonucleolytic site of DNA polymerase I. Science (1988) 4.50
A novel cysteine-rich sequence motif. Cell (1991) 4.39
Role of SUMO-1-modified PML in nuclear body formation. Blood (2000) 4.05
PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia. Oncogene (1996) 3.73
Analysis of the relationship between side-chain conformation and secondary structure in globular proteins. J Mol Biol (1987) 3.63
Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia. Science (1991) 3.57
Evaluation and improvements in the automatic alignment of protein sequences. Protein Eng (1989) 3.57
Large-scale chromatin organization of the major histocompatibility complex and other regions of human chromosome 6 and its response to interferon in interphase nuclei. J Cell Sci (2000) 3.50
Structure of the AAA ATPase p97. Mol Cell (2000) 3.37
Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science (1990) 3.34
Crystallographic studies of the dynamic properties of lysozyme. Nature (1979) 3.30
Cancer incidence in the United Kingdom: projections to the year 2030. Br J Cancer (2011) 3.23
Plasticity in the organization and sequences of human KIR/ILT gene families. Proc Natl Acad Sci U S A (2000) 3.09
Knowledge-based prediction of protein structures and the design of novel molecules. Nature (1987) 2.99
PML protein isoforms and the RBCC/TRIM motif. Oncogene (2001) 2.99
The RING finger domain: a recent example of a sequence-structure family. Curr Opin Struct Biol (1996) 2.97
The solution structure of the RING finger domain from the acute promyelocytic leukaemia proto-oncoprotein PML. EMBO J (1995) 2.93
Combinatorial generation of variable fusion proteins in the Ewing family of tumours. EMBO J (1993) 2.91
The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudson's 'two-hit' hypothesis. Nat Med (1999) 2.76
Cervical sampling devices. BMJ (1996) 2.74
Structure of an XRCC1 BRCT domain: a new protein-protein interaction module. EMBO J (1998) 2.68
CpG island clones from a deletion encompassing the gene for adenomatous polyposis coli. Proc Natl Acad Sci U S A (1989) 2.66
Left-handed polyproline II helices commonly occur in globular proteins. J Mol Biol (1993) 2.62
Sentinel node biopsy in cutaneous melanoma: time for consensus to better inform patient choice. Br J Dermatol (2015) 2.61
Identification and preliminary characterization of a protein motif related to the zinc finger. Proc Natl Acad Sci U S A (1993) 2.55
Identification and analysis of domains in proteins. Protein Eng (1995) 2.54
The crystal structure of the human DNA repair endonuclease HAP1 suggests the recognition of extra-helical deoxyribose at DNA abasic sites. EMBO J (1997) 2.53
A novel zinc finger coiled-coil domain in a family of nuclear proteins. Trends Biochem Sci (1992) 2.51
Use of pair potentials across protein interfaces in screening predicted docked complexes. Proteins (1999) 2.49
Automated structure-based prediction of functional sites in proteins: applications to assessing the validity of inheriting protein function from homology in genome annotation and to protein docking. J Mol Biol (2001) 2.46
SUMO-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear localisation. J Cell Sci (1999) 2.46
Identification and application of the concepts important for accurate and reliable protein secondary structure prediction. Protein Sci (1996) 2.42
Effect of smoking cessation on cervical lesion size. Lancet (1996) 2.35
Side-chain conformational entropy in protein folding. Protein Sci (1995) 2.35
A systematic review of the role of human papillomavirus testing within a cervical screening programme. Health Technol Assess (1999) 2.32
Rapid refinement of protein interfaces incorporating solvation: application to the docking problem. J Mol Biol (1998) 2.30
The human polycomb group complex associates with pericentromeric heterochromatin to form a novel nuclear domain. J Cell Biol (1998) 2.29
Empirical scale of side-chain conformational entropy in protein folding. J Mol Biol (1993) 2.29
The binding site on ICAM-1 for Plasmodium falciparum-infected erythrocytes overlaps, but is distinct from, the LFA-1-binding site. Cell (1992) 2.29
Trends in cervical cancer mortality. Lancet (1991) 2.28
Similarity in membrane proteins. Nature (1989) 2.05
The isolation and characterization of colorectal epithelial cell lines at different stages in malignant transformation from familial polyposis coli patients. Int J Cancer (1984) 2.04
Chromosomal localisation of the human homologues to the oncogenes erbA and B. EMBO J (1984) 2.02
Comparative genomic hybridization of breast tumors stratified by histological grade reveals new insights into the biological progression of breast cancer. Cancer Res (1999) 2.02
Oligomeric ring structure of the Bloom's syndrome helicase. Curr Biol (1999) 2.01
Olfactory receptor gene cluster on human chromosome 17: possible duplication of an ancestral receptor repertoire. Hum Mol Genet (1994) 2.00
The human placental alkaline phosphatase gene and related sequences map to chromosome 2 band q37. Ann Hum Genet (1987) 2.00
Accelerated decline in cervical cancer mortality in England and Wales. Lancet (1995) 1.95
Genetic evidence that a Y-linked gene in man is homologous to a gene on the X chromosome. Nature (1983) 1.94
Benchmarking PSI-BLAST in genome annotation. J Mol Biol (1999) 1.87
Supersites within superfolds. Binding site similarity in the absence of homology. J Mol Biol (1998) 1.87
Spectral karyotyping suggests additional subsets of colorectal cancers characterized by pattern of chromosome rearrangement. Proc Natl Acad Sci U S A (2001) 1.85
New algorithm to model protein-protein recognition based on surface complementarity. Applications to antibody-antigen docking. J Mol Biol (1992) 1.85
Recognition of analogous and homologous protein folds: analysis of sequence and structure conservation. J Mol Biol (1997) 1.83
RING1 is associated with the polycomb group protein complex and acts as a transcriptional repressor. Mol Cell Biol (1997) 1.83
Vpr is preferentially targeted by CTL during HIV-1 infection. J Immunol (2001) 1.82
An automated classification of the structure of protein loops. J Mol Biol (1997) 1.77
Crystal structure of the DNA modifying enzyme beta-glucosyltransferase in the presence and absence of the substrate uridine diphosphoglucose. EMBO J (1994) 1.76
Model building by comparison at CASP3: using expert knowledge and computer automation. Proteins (1999) 1.76
Isolation of cDNA clones encoding the beta isozyme of human DNA topoisomerase II and localisation of the gene to chromosome 3p24. Nucleic Acids Res (1992) 1.74
APC in the regulation of intestinal crypt fission. J Pathol (1998) 1.73
Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study. Br J Cancer (1996) 1.71
Characterisation of human thyroid epithelial cells immortalised in vitro by simian virus 40 DNA transfection. Br J Cancer (1989) 1.68
A continuum model for protein-protein interactions: application to the docking problem. J Mol Biol (1995) 1.68
On the conformation of proteins: the handedness of the connection between parallel beta-strands. J Mol Biol (1977) 1.66
Structure, organization, and dynamics of promyelocytic leukemia protein nuclear bodies. Am J Hum Genet (1998) 1.64
An analysis of conformational changes on protein-protein association: implications for predictive docking. Protein Eng (1999) 1.63
Two simple procedures for releasing chromatin from routinely fixed cells for fluorescence in situ hybridization. Cytogenet Cell Genet (1994) 1.61
Chromosomal locations of the gene coding for the CD3 (T3) gamma subunit of the human and mouse CD3/T-cell antigen receptor complexes. Immunogenetics (1987) 1.60
Molecular cloning and tissue expression of FAT, the human homologue of the Drosophila fat gene that is located on chromosome 4q34-q35 and encodes a putative adhesion molecule. Genomics (1995) 1.59
Analysis and prediction of the location of catalytic residues in enzymes. Protein Eng (1988) 1.59
Neu receptor dimerization. Nature (1989) 1.58
The BRCA1 C-terminal domain: structure and function. Mutat Res (2000) 1.57
Localization of the oncogene c-erbA1 immediately proximal to the acute promyelocytic leukaemia breakpoint on chromosome 17. Ann Hum Genet (1985) 1.55
Differential expression of keratins 10, 17, and 19 in normal cervical epithelium, cervical intraepithelial neoplasia, and cervical carcinoma. J Clin Pathol (1999) 1.54
Cancer mortality in the United Kingdom: projections to the year 2025. Br J Cancer (2008) 1.52
Refining the Amsterdam Criteria and Bethesda Guidelines: testing algorithms for the prediction of mismatch repair mutation status in the familial cancer clinic. J Clin Oncol (2004) 1.51
The crystal structure of the catalytic domain of the site-specific recombination enzyme gamma delta resolvase at 2.7 A resolution. Cell (1990) 1.49
Dynamic information from protein crystallography. An analysis of temperature factors from refinement of the hen egg-white lysozyme structure. J Mol Biol (1979) 1.49
A monoclonal antibody recognizing a cell surface antigen coded for by a gene on human chromosome 17. Ann Hum Genet (1982) 1.46
Sampling methods for cervical smears. Acta Cytol (1992) 1.45
Characterization and chromosomal assignment of a human cell surface antigen defined by the monoclonal antibody AUAI. Int J Cancer (1986) 1.45
Identification of sequence motifs from a set of proteins with related function. Protein Eng (1994) 1.44
The impact of Jade Goody's diagnosis and death on the NHS Cervical Screening Programme. J Med Screen (2012) 1.44
SAWTED: structure assignment with text description--enhanced detection of remote homologues with automated SWISS-PROT annotation comparisons. Bioinformatics (2000) 1.44
Diagnosis of Ewing's sarcoma and peripheral neuroectodermal tumour based on the detection of t(11;22) using fluorescence in situ hybridisation. Br J Cancer (1993) 1.42